CWM
GILD icon

Calamos Wealth Management’s Gilead Sciences GILD Stock Holding History

Calamos Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482K Sell
3,817
-1,974
-34% -$260K 0.01% 308
2026
Q1 		$807K Buy
5,791
+2,699
+87% +$378K 0.03% 235
2025
Q4 		$380K Sell
3,092
-456
-13% -$55.4K 0.01% 313
2025
Q3 		$394K Buy
+3,548
New +$403K 0.01% 298
2023
Q3 		– Sell
-4,428
Closed -$341K – 332
2023
Q2 		$341K Buy
4,428
+277
+7% +$22.1K 0.03% 237
2023
Q1 		$344K Sell
4,151
-188
-4% -$15.6K 0.03% 243
2022
Q4 		$373K Buy
+4,339
New +$344K 0.03% 232
2017
Q2 		– Sell
-39,260
Closed -$2.67M – 228
2017
Q1 		$2.67M Buy
39,260
+5,533
+16% +$389K 0.4% 76
2016
Q4 		$2.42M Sell
33,727
-5,063
-13% -$376K 0.39% 78
2016
Q3 		$3.07M Buy
38,790
+1,627
+4% +$132K 0.52% 62
2016
Q2 		$3.1M Buy
37,163
+10,492
+39% +$931K 0.55% 54
2016
Q1 		$2.45M Buy
26,671
+4,581
+21% +$413K 0.47% 63
2015
Q4 		$2.23M Buy
22,090
+1,131
+5% +$118K 0.45% 67
2015
Q3 		$2.06M Buy
20,959
+1,155
+6% +$128K 0.49% 60
2015
Q2 		$2.32M Buy
19,804
+10,536
+114% +$1.15M 0.55% 52
2015
Q1 		$909K Sell
9,268
-5,178
-36% -$526K 0.23% 144
2014
Q4 		$1.36M Sell
14,446
-4,417
-23% -$457K 0.39% 98
2014
Q3 		$2.01M Sell
18,863
-10,856
-37% -$1.06M 0.58% 58
2014
Q2 		$2.46M Buy
29,719
+60
+0.2% +$4.67K 0.7% 43
2014
Q1 		$2.1M Buy
29,659
+6,545
+28% +$513K 0.62% 54
2013
Q4 		$1.74M Sell
23,114
-625
-3% -$43.5K 0.53% 78
2013
Q3 		$1.49M Sell
23,739
-12,336
-34% -$737K 0.49% 83
2013
Q2 		$1.85M Buy
+36,075
New +$1.88M 0.65% 55

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Calamos Wealth Management's GILD Position: Q2 2026 in Review

Calamos Wealth Management reduced its Gilead Sciences (GILD) stake by 34% in Q2 2026, selling an estimated $260K and leaving 3,817 shares worth $482K. The position accounts for 0.01% of the portfolio, ranked #308.

Calamos Wealth Management first reported a position in GILD in Q2 2013 and has held it in 23 quarters since. The position peaked at $3.1M in Q2 2016. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Calamos Wealth Management held 3,817 shares of Gilead Sciences worth $482K as of Q2 2026.
  • Calamos Wealth Management sold 1,974 Gilead Sciences shares in Q2 2026, an estimated $260K.
  • Gilead Sciences made up 0.01% of Calamos Wealth Management's portfolio in Q2 2026, its #308 holding.
  • Calamos Wealth Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 23 quarters since.
  • Calamos Wealth Management's Gilead Sciences position peaked at $3.1M in Q2 2016.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Calamos Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.